1. Home
  2. GUT vs ORGO Comparison

GUT vs ORGO Comparison

Compare GUT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GUT
  • ORGO
  • Stock Information
  • Founded
  • GUT 1999
  • ORGO 1985
  • Country
  • GUT United States
  • ORGO United States
  • Employees
  • GUT N/A
  • ORGO N/A
  • Industry
  • GUT Trusts Except Educational Religious and Charitable
  • ORGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GUT Finance
  • ORGO Health Care
  • Exchange
  • GUT Nasdaq
  • ORGO Nasdaq
  • Market Cap
  • GUT 535.8M
  • ORGO 620.3M
  • IPO Year
  • GUT N/A
  • ORGO N/A
  • Fundamental
  • Price
  • GUT $6.02
  • ORGO $4.02
  • Analyst Decision
  • GUT
  • ORGO Buy
  • Analyst Count
  • GUT 0
  • ORGO 3
  • Target Price
  • GUT N/A
  • ORGO $7.33
  • AVG Volume (30 Days)
  • GUT 176.3K
  • ORGO 819.3K
  • Earning Date
  • GUT 01-01-0001
  • ORGO 11-06-2025
  • Dividend Yield
  • GUT 10.93%
  • ORGO N/A
  • EPS Growth
  • GUT N/A
  • ORGO N/A
  • EPS
  • GUT N/A
  • ORGO N/A
  • Revenue
  • GUT N/A
  • ORGO $429,531,000.00
  • Revenue This Year
  • GUT N/A
  • ORGO $2.51
  • Revenue Next Year
  • GUT N/A
  • ORGO $25.45
  • P/E Ratio
  • GUT N/A
  • ORGO N/A
  • Revenue Growth
  • GUT N/A
  • ORGO N/A
  • 52 Week Low
  • GUT $4.60
  • ORGO $2.61
  • 52 Week High
  • GUT $7.38
  • ORGO $6.71
  • Technical
  • Relative Strength Index (RSI)
  • GUT 52.45
  • ORGO 36.21
  • Support Level
  • GUT $5.94
  • ORGO $4.02
  • Resistance Level
  • GUT $6.08
  • ORGO $4.40
  • Average True Range (ATR)
  • GUT 0.07
  • ORGO 0.23
  • MACD
  • GUT -0.00
  • ORGO -0.05
  • Stochastic Oscillator
  • GUT 64.71
  • ORGO 3.83

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: